Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-01-24 Brister Mark Chief Technology Officer Grant or award · Restricted Stock Units +110,281 110,281
2019-10-25 Brister Mark Chief Technology Officer Grant or award · Stock Option (Right to Buy) +13,000 13,000
2019-08-06 Brister Mark Chief Technology Officer Purchase +5,000 $4.00 $20K 38,865
2019-08-06 Brister Mark Chief Technology Officer Purchase · Warrants (Right to Buy) +3,750 3,750
2019-07-23 Brister Mark Chief Technology Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2019-01-02 Brister Mark Chief Technology Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2018-08-23 Brister Mark Chief Technology Officer Grant or award +107,142 $1.82 $195K 338,634
2018-04-30 Brister Mark Chief Technology Officer Grant or award +2,622 $3.27 $9K 166,492
2018-01-02 Brister Mark Chief Technology Officer Grant or award +65,000 65,000
2017-10-31 Brister Mark Chief Technology Officer Grant or award +1,860 $7.17 $13K 163,870
2017-04-30 Brister Mark VP of Research and Development Grant or award +1,550 $9.03 $14K 162,010
2016-11-09 Brister Mark VP of Research and Development Grant or award · Stock Option (right to buy) +90,000 90,000

Page 1 of 1 · 12 trades